Masks For Sickle Cell Families – A COVID-19 Relief Effort

During these uncertain times, MTS Sickle Cell Foundation is here for you. We recognize the unique concerns of sickle cell families during the COVID-19 pandemic, and are amplifying our efforts to provide you with information and support.

Our second COVID-19 support efforts will help families navigate life during these trying time. We have partnered with individuals and businesses to help us provide up to 2 cloth masks per household to help meet the needs of Sickle Cell families across the United States. See below for eligibility requirements and instructions on how to apply.

**As a non-profit organization, we rely on the generosity of our sponsors. Program continuation is contingent on the availability of funds. The program could be modified or discontinued at any time if funding is limited or no longer available.**

Eligibility Requirements

  • Patients/Caregivers must be U.S. citizens or permanent residents and reside in the U.S.
  • Patients must have a confirmed sickle cell disease diagnosis, be in active treatment, scheduled to begin treatment or in follow up care, all attested by the patient or care team member.
  • There is no income criteria.
  • Patients may be insured or uninsured.
  • Patients do not need to have a COVID-19 diagnosis.

Required Information for Application

  • The patient’s Sickle Cell Disease diagnosis
  • Physician’s information (first and last name, and location)

We Want to Hear How This Program Has Helped You!

We would love to hear how the support provided by MTS Sickle Cell Foundation has helped you. Patient stories help us illustrate the impact and importance of this program in the lives of families affected by Sickle Cell Disease.

MESSAGE US YOUR STORY ON FACEBOOK

Program Support

MTS Sickle Cell Foundation is a nonprofit organization that relies on the generosity of individual, foundation and corporate contributions to advance its mission. The Masks For Sickle Cell Families – A COVID-19 Relief Effort is supported in partnership with:

Comments are closed